InvestorsHub Logo
Followers 0
Posts 37
Boards Moderated 0
Alias Born 04/09/2009

Re: dDT post# 10735

Sunday, 09/12/2010 4:32:02 PM

Sunday, September 12, 2010 4:32:02 PM

Post# of 48121
OXGN news AH

.•ZYBRESTAT(TM) (CA4P) Improves Overall Survival in a Phase 2/3 Trial (FACT Study) of Patients With Anaplastic Thyroid Cancer (ATC)

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.